secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outlook Therapeutics, Inc. (OTLK)
CIK:        0001649989
Form:       8-K
Filed at:   2024-04-15T23:59:59+00:00
Accession:  0001104659-24-047322
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Outlook Therapeutics closes $5M private placement to Syntone Ventures
---------------------------------------------------------------------

- Issued 714,286 shares and warrants to purchase 1,071,429 shares at $7.00 per share+ warrant.
- Warrant exercise price is $7.70 per share, expiring April 15, 2029.
- Sale relied on Section 4(a)(2) and Rule 506 exemptions without registration.
- Syntone Ventures LLC is the sole investor in the private placement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649989/000110465924047322/0001104659-24-047322-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649989/000110465924047322/tm2411870d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-047322

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer